Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Hlavní autoři: | , , , , , , , , , |
---|---|
Médium: | Conference item |
Vydáno: |
Oxford University Press
2017
|
Shrnutí: |
---|